You are here

  • Home
  • Archive
  • Volume 10, Issue 8
  • Antitumor efficacy of 90Y-NM600 targeted radionuclide therapy and PD-1 blockade is limited by regulatory T cells in murine prostate tumors

Citation Tools

Article menu
Clinical/translational cancer immunotherapy
Original research
Antitumor efficacy of 90Y-NM600 targeted radionuclide therapy and PD-1 blockade is limited by regulatory T cells in murine prostate tumors

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Potluri HK, Ferreira CA, Grudzinski J, et al
Antitumor efficacy of 90Y-NM600 targeted radionuclide therapy and PD-1 blockade is limited by regulatory T cells in murine prostate tumors
Journal for ImmunoTherapy of Cancer 2022;10:e005060. doi: 10.1136/jitc-2022-005060